Scientist – Global Clinical Pharmacology (1 of 2)

Janssen Research & Development, L.L.C., a Johnson & Johnson company, is recruiting a Scientist in Global Clinical Pharmacology to be located in: Raritan, NJ, Titusville, NJ and/or Spring House, PA.

At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found. 


Janssen Research & Development, LLC discovers and develops innovative medical solutions to address important unmet medical needs in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Please visit for more information. 


We are Janssen. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it.

The Therapeutic Area (TA) Scientist Global Clinical Pharmacology (GCP) role is to apply and promote GCP knowledge, including pharmacokinetics/pharmacodynamics analyses and principles of model-based drug development in the programs for all stages of drug development ranging from pre-New Molecular Entity (NME) declaration through Post-Marketing support, in collaboration with senior scientist in the group, various stakeholders, QS-Project Matrix teams, CP and PM Leaders. With oversight, the TA Scientist GCP can also execute the day-to-day operations for the clinical pharmacology aspects of the assigned programs.


The TA Scientist GCP can directly impact the operational results, as they are focused on investigation and characterization of how drugs interact with biological systems or diseases so they can be used safely and effectively, and with the appropriate pharmaceutical formulation.

  • With guidance from senior members of the group, applies the understanding of (1) the impact of intra- and inter-subject variability in physiology and/or pathology, concomitant medication use, and biopharmaceutics, on pharmacokinetics (PK) and PK/pharmacodynamics (PD), and (2) requirements for the clinical pharmacology regulatory submission packages and submission processes. 
  • Assist CP and PM Leaders with the execution of scientifically robust and efficient clinical pharmacology strategies for NME and/or development candidates. 
  • Carries out functional responsibilities in accordance to applicable SOPs, regulatory requirements and Johnson & Johnson Credo principles.
Accountabilities with assistance from senior members of the group:
  • Contribute to overall compound development via application of quantitative methods to integrate knowledge of PK, PD, patient characteristics, disease states, and drug-drug interactions to optimize dose selection, dosage regimens and study designs throughout drug development. With assistance from senior members, the TA Scientist GCP will translate quantitative knowledge into strategic opportunities with key stake holders to drive development along the model-based drug development principles.
  • Assist CP and PM Leaders with modeling and simulation activities in drug development programs. Perform and/or liaise for modeling and simulation analysis of preclinical-clinical data, translational PK/PD data, up to first-in-human (FIH) and if applicable beyond FIH (dose/exposure-response analyses to guide dose regimen from pre-proof of concept (POC) and POC studies). 

Additional accountabilities:

  • Help with design of Phase I Clinical Pharmacology studies.
  • Manage operational elements of GCP studies with respective project CP Leaders.
  • Perform literature searches and summarize the findings.
  • Help design and execute PK, PK/PD modeling efforts to address the unique challenges pertinent to the project.
  • Contribute to preparation of monographs, INDs and other documents as applicable to support clinical studies.
  • Remain current with clinical and drug development information and methods in modeling and simulation by engaging with the scientific community (e.g., publishing, presenting at meetings, participating in special interest groups within professional societies, etc.) and internalize key learnings back to Janssen.
  • Support CP and PM Leaders with ad hoc analyses, not limited to non-compartmental analyses in support of Phase I studies.
  • Work effectively in matrix environment, managing CP deliverables in accordance with timelines and overall project goals.
  • Apply appropriate regulatory (e.g., FDA, EMEA, ICH, etc.) guidelines in the design of clinical development plans and studies.
  • Apply relevant technical trainings/learnings to daily responsibilities, with focus of opportunistic deliver of value/impact.

Required Knowledge and Skills:
  • MS, PharmD, PhD or equivalent degree in Pharmaceutical Sciences, Clinical Pharmacology, Biomedical Engineering, or relevant Biological Sciences. Ph.D. degree or equivalent, with 0-1+ years of relevant experience (including postdoctoral studies)or a MS or PharmD degree or equivalent, with 3+ years of relevant experience performing progressively advanced duties.
  • Has established a level of expertise and scientific reputation through publications and/or presentations is preferred
  • Has a background to influence the drug development in one or multiple Therapeutic Areas is preferred.
  • Has an understanding of model based drug development (MBDD), biopharmaceutics classification system (BCS), and knowledge of biostatistics principles and tools (e.g., Gastroplus, Simcyp, Winnonlin, NONMEM) and demonstrated ability to apply these tools to enable rational and efficient drug development is required.
  • Experience or working knowledge of US, European, and Asian (including BRIC countries) regulatory requirements and guidelines is preferred.  
  • Understanding of PK, PD, PK/PD, and Translational Medicine is required.
  • Ability to interpret PK and PKPD results and prepare presentations to illustrate findings accurately is required.
  • A basic and or working knowledge of disease processes and mechanisms, available treatment paradigms, and patient populations within assigned Therapeutic Area is preferred.

Primary Location
United States-New Jersey-Titusville
Other Locations
North America-United States-Pennsylvania-Spring House, North America-United States-New Jersey-Raritan
Janssen Research & Development, LLC. (6084)
Job Function
Requisition ID

Share this Job

Other Locations For This Job